bpc-157 news fda advisory committee recommends for 503a bulks list UNDER SCRUTINY: Seven peptides go

Tendon and Ligament Repair Moderate to Strong Evidence Evidence Rating: Moderate-Strong (Several animal studies, some independent replication) Research support for musculoskeletal healing is substantial: Achilles tendon injuries Ligament damage (MCL, ACL) Rotator cuff healing General tendinopathy Surgical repair enhancement The FAK-paxillin mechanism and VEGF upregulation provide clear biological rationale for these effects

BPC-157 was on the FDA 503A Category 2 compounding-restriction list from September 2023 until around April 2026, when it was removed

Follow-up laboratory testing should occur 8-12 weeks after initiating supplementation to confirm adequate response, with ongoing monitoring as clinically indicated

However, because these breath tests are neither sensitive nor specific (up to 60% false negatives), most Functional doctors will treat a patient when they exhibit classic symptoms